Patients’ perceptions and experiences of larval therapy

Kitching, Mark

doi:10.12968/jowc.2004.13.1.26560

Cited by 52 publications

(36 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, most patients fully accept larval therapy, especially when thoroughly informed about the method, and its advantages and sideeffects (42). The maggots have to be protected from crushing and exsiccation, and the transudate external layer of the dressing should often be exchanged.…”

Section: Discussionmentioning

confidence: 99%

Biosurgical Treatment Results in Patients with Chronic Crural and Foot Ulcerations

Jarczyk¹,

Jackowski²,

Szpila³

et al. 2008

Polish Journal of Surgery

View full text Add to dashboard Cite

Blowfly maggots have been used in the treatment of wounds since antiquity. For more than ten years, advances in modern technology have enabled us to safely and widely apply larval therapy as one of the methods used to treat poorly healing ulcerations. The aim of the study was to determine the degree of non-healing wound debridement after the application of sterile Lucilia sericata blowfly maggots. Material and methods. The study group comprised 19 patients including 15 with crural ulcerations due to chronic venous insufficiency and four with diabetic feet. Each was subjected to larval therapy. Five patients were additionally diagnosed with advanced lower leg atherosclerosis. The study group comprised 12 female and 7 male patients between 48 and 86 years of age. The ulcerations were present for a period ranging between 1 and 420 months before the study. Twenty-one wounds were analyzed. The type and degree of vascular insufficiency of the lower legs was evaluated on the basis of Doppler ultrasound examinations utilizing the ankle/brachial index. Lucilia sericata blowfly maggots were placed in the wound, ten for every 1 cm 2 , and left for a period of 2-3 days. The external part of the dressing was changed 2-3 times per day. In addition to photographic documentation of the wound, swabs were collected for bacteriological examination before and after treatment. Results. The surface area of the wounds subjected to larval therapy ranged between 2 and 139 cm 2 . The mean surface area for venous ulcerations was 60 cm 2 , whereas, the mean for diabetic ulcerations was 47 cm 2 . The maggots were applied once to 9 wounds, twice to 4 wounds, three times to 4 wounds, four times to 3 wounds, and five times to one wound. Nine of the ulcerations were debrided from necrotic tissue by 90-100%, six by 70-90%, two by 55-60%, and three by 20-40%. In the case of one patient, the wound was not cleansed and the limb was amputated. Good biosurgical treatment results prevented three patients with diabetic feet from possible amputation at the level of the thigh (two patients), and lower leg (one patient). Debridement results were worse in patients where therapy was stopped due to acute pain (two patients) or significant bleeding (two patients), as well as in those with concomitant atherosclerosis. Conclusions. Biosurgical treatment of chronic lower leg ulcerations with the use of sterile Lucilia sericata blowfly maggots is a safe and effective method on the basis of debridement of wounds from necrotic tissue and purulent exudate.

show abstract

Section: Discussionmentioning

confidence: 99%

Biosurgical Treatment Results in Patients with Chronic Crural and Foot Ulcerations

Jarczyk¹,

Jackowski²,

Szpila³

et al. 2008

Polish Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Há relatos em que a TL foi melhor compreendida e aceita após surgirem resultados positivos durante o tratamento 7 . Considerando-se com isso, que a adesão das pessoas à TL é um fator central para a expansão desta bioterapia 8 .…”

Section: Letícia Cunha Francounclassified

“…Concluíram que a experiência com a TL não foi tão assustadora como imaginavam e a resistência inicial advinda da repulsa dos clientes às larvas foi vencida após o início do tratamento e surgimento das evidências de sucesso na cicatrização das feridas. Também foi observado que o relacionamento enfermeiro-cliente foi fator importante na aceitação da TL, concomitante à autonomia e escolha informada 7 . Na investigação da opinião de médicos e enfermeiros acerca da terapia com larvas em unidades de assistência à saúde no CentroOeste do Brasil, observou-se que 48,1% aceitaria utilizar esse tratamento no próprio corpo e 51,8% aceitaria aplicar a TL no corpo de outras pessoas 11 .…”

Section: Letícia Cunha Francounclassified

“…Os estudos encontrados acerca da aceitabilidade da terapia com larvas de moscas também corroboram com nossos resultados, pois demostram boa aceitação da TL, apontando para a necessidade de expansão do acesso a este tratamento 7,8,10,11 . Com isso, nota-se a ne cessidade de ampliação da divulgação das terapias empregadas no cuidado de feridas, para que a ausência de informação não seja o fator impeditivo a aproximação às diferentes tecnologias, como a TL.…”

Section: Materials E Métodounclassified

See 1 more Smart Citation

Aceitabilidade da terapia larval no tratamento de feridas

Franco¹,

Franco²,

Barros³

et al. 2016

Revista Recien

View full text Add to dashboard Cite

Resumo: Conhecer a opinião de pessoas hospitalizadas acerca da terapia larval como opção terapêutica. Estudo do tipo transversal e descritivo, realizado no setor de clínica médica e cirúrgica de um hospital de ensino, por meio de entrevista. Participaram da pesquisa 105 pessoas, dentre essas, 6 souberam dizer o que é uma bioterapia, 95 afirmaram que utilizariam a terapia larval, 32 se sentiam motivadas em aderir o tratamento devido à possibilidade de diminuir seus níveis de dor e 73 referiram medo em perder a vida. A terapia larval foi bem aceita entre as pessoas hospitalizadas e que referiram medo de morrer. Ressalta-se a importância da divulgação e do acesso a essa terapia natural, para ampliar as opções de tratamento e a qualidade de vida das pessoas hospitalizadas .Descritores: Larvas, Feridas, Cuidado. Acceptability of maggot therapy in wound careAbstract: Know the opinion of people hospitalized about maggot therapy as a treatment option. Cross-sectional and descriptive study conducted in medical clinic and surgical medicine in a teaching hospital, through interviews. The participants were 105 people, among these, six were able to say what was a biotherapy, 95 said they wo uld use the maggot therapy, 32 felt motivated to join the treatment because of the possibility to reduce their pain levels and 73 mentioned fear of losing their lives. Maggot therapy was well accepted among hospitalized people and those who feared losing their lives. It emphasizes the importance of dissemination and the access to this natural therapy, to expand treatment options and quality of life of hospitalized persons .Descriptor s: Maggot, Wound, Care. La aceptabilidad de la terapia larval en el tratamiento de heridasResumen: Conocer la opinión de las personas hospitalizadas acerca de la terapia larval como una opción en el tratamiento. Es un estudio transversal y descriptivo, realizado en el departamento médico y quirúrgico de un hospital universitario, a través de entrevista. Participaron de la encuesta 105 personas, entre ellos, 6 supieron lo que era una bioterapia, 95 dijeron que usarían la terapia larval, 32 estaban motivados en la adhesión de este tratamiento, debido a la posibilidad de disminuir sus niveles de dolor y el 73 dijeron tener miedo de perder la vida. La terapia larval fue bien aceptada por las personas hospitalizadas y que dijeron tener miedo de morir. Se hace hincapié en la importancia de la publicidad y el acceso a esta terapia natural, para ampliar las opciones de tratamiento y la calidad de vida de las personas hospitalizad as.

show abstract

“…Three studies have investigated the patient acceptability of larval therapy. 47,48,83 As part of the development of this study we used a questionnaire to assess leg ulcer patients' preferences for loose larvae (versus hydrogel) and bagged larvae (versus hydrogel) by measuring the improvement in healing time that the patients would require in order for them to prefer larval therapy over hydrogel. 47 In total, 41 patients completed a questionnaire (they were randomised to receive either a loose larvae or a bagged larvae questionnaire), with 25% stating they would never use larvae.…”

Section: Acceptability Of Larval Therapymentioning

confidence: 99%

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

Dumville

Worthy²,

Soares³

et al. 2009

Health Technol Assess

View full text Add to dashboard Cite

EA Nelson and DJ Torgerson on behalf of the VenUS II teamHow to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for HealthResearch (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions f...

show abstract

Patients’ perceptions and experiences of larval therapy

Abstract: The findings suggest that, although initially repellent, larval therapy is acceptable once treatment starts. The nurse-patient relationship was a significant factor in acceptance, along with autonomy and informed choice.

Cited by 52 publications

References 19 publications

Biosurgical Treatment Results in Patients with Chronic Crural and Foot Ulcerations

Biosurgical Treatment Results in Patients with Chronic Crural and Foot Ulcerations

Aceitabilidade da terapia larval no tratamento de feridas

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

Contact Info

Product

Resources

About